Cargando…
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma
The incidence of cutaneous squamous cell carcinoma (cSCC) is rising. Whilst the majority are cured surgically, aggressive metastatic cSCC carry a poor prognosis. Inactivating mutations in transforming growth factor beta (TGF-β) receptors have been identified amongst genetic drivers of sporadic tumou...
Autores principales: | Rose, Aidan M., Spender, Lindsay C., Stephen, Christopher, Mitchell, Alastair, Rickaby, William, Bray, Susan, Evans, Alan T., Dayal, Jasbani, Purdie, Karin J., Harwood, Catherine A., Proby, Charlotte M., Leigh, Irene M., Coates, Philip J., Inman, Gareth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865689/ https://www.ncbi.nlm.nih.gov/pubmed/29581863 http://dx.doi.org/10.18632/oncotarget.24545 |
Ejemplares similares
-
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
por: Cammareri, Patrizia, et al.
Publicado: (2016) -
The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
por: Inman, Gareth J., et al.
Publicado: (2018) -
NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis
por: South, Andrew P, et al.
Publicado: (2014) -
The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions
por: Purdie, Karin J., et al.
Publicado: (2018) -
A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing
por: Hassan, Sakinah, et al.
Publicado: (2019)